none14noneFloridia M; Tamburrini E; Anzidei G; Tibaldi C; Guaraldi G; Guerra B; Meloni AM; Vimercati A; Molinari A; Pinnetti C; Dalzero S; Ravizza M; Faldella G; Italian Group on Surveillance on Antiretroviral Treatment in PregnancyFloridia M; Tamburrini E; Anzidei G; Tibaldi C; Guaraldi G; Guerra B; Meloni AM; Vimercati A; Molinari A; Pinnetti C; Dalzero S; Ravizza M; Faldella G; Italian Group on Surveillance on Antiretroviral Treatment in Pregnanc
none18noBACKGROUND: Atazanavir and lopinavir represent the main HIV protease inhibitors recommended ...
To define serum lipid changes in HIV-infected pregnant women undergoing antiretroviral treatment, cl...
Background: The risk of vertical transmission of HIV has been substantially reduced since the introd...
Abstract Limited information is currently available on the metabolic profile of nevirapine in pregna...
OBJETIVO: avaliar o efeito das medicações anti-retrovirais sobre o metabolismo lipídico em gestantes...
Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the ...
Background: Undesirable changes in lipid metabolism have been reported among HIV-infected individual...
Abstract Background Observed adverse effects of antiretroviral therapy (ART) on the lipid profile co...
BACKGROUND: Observed adverse effects of antiretroviral therapy (ART) on the lipid profile could be o...
OBJECTIVES: Optimal plasma concentrations of antiretroviral drugs are required during pregnancy to t...
OBJECTIVES: Optimal plasma concentrations of antiretroviral drugs are required during pregnancy to t...
International audienceHighly active antiretroviral therapy is recommended for HIV-infected pregnant ...
BACKGROUND: Highly active antiretroviral therapy(HAART) is used in pregnancy to suppress viral load(...
Plasma nelfinavir concentration ratios (CRs) were calculated for all pregnant ( ) and nonpregnant ( ...
none18noBACKGROUND: Atazanavir and lopinavir represent the main HIV protease inhibitors recommended ...
To define serum lipid changes in HIV-infected pregnant women undergoing antiretroviral treatment, cl...
Background: The risk of vertical transmission of HIV has been substantially reduced since the introd...
Abstract Limited information is currently available on the metabolic profile of nevirapine in pregna...
OBJETIVO: avaliar o efeito das medicações anti-retrovirais sobre o metabolismo lipídico em gestantes...
Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the ...
Background: Undesirable changes in lipid metabolism have been reported among HIV-infected individual...
Abstract Background Observed adverse effects of antiretroviral therapy (ART) on the lipid profile co...
BACKGROUND: Observed adverse effects of antiretroviral therapy (ART) on the lipid profile could be o...
OBJECTIVES: Optimal plasma concentrations of antiretroviral drugs are required during pregnancy to t...
OBJECTIVES: Optimal plasma concentrations of antiretroviral drugs are required during pregnancy to t...
International audienceHighly active antiretroviral therapy is recommended for HIV-infected pregnant ...
BACKGROUND: Highly active antiretroviral therapy(HAART) is used in pregnancy to suppress viral load(...
Plasma nelfinavir concentration ratios (CRs) were calculated for all pregnant ( ) and nonpregnant ( ...
none18noBACKGROUND: Atazanavir and lopinavir represent the main HIV protease inhibitors recommended ...
To define serum lipid changes in HIV-infected pregnant women undergoing antiretroviral treatment, cl...
Background: The risk of vertical transmission of HIV has been substantially reduced since the introd...